The DOI matches its Crossref record; 359 of the 359 references it cites were found in a registry or an index.
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTNext Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic AreasYu Zhou†, Jiang Wang†, Zhanni Gu†, Shuni Wang†, Wei Zhu†, José Luis Aceña*‡§, Vadim A. Soloshonok*‡∥, Kunisuke Izawa*⊥, and Hong Liu*†View Author Information† Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China‡ Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, 20018 San Sebastián, Spain§ Department of Organic Chemistry, Autónoma University of Madrid, Cantoblanco, 28049 Madrid, Spain∥ IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, 48013 Bilbao, Spain⊥ Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024*E-mail: [email protected]*E-mail: [email protected]*E-mail: [email protected]*E-mail: [email protected]Cite this: Chem. Rev. 2016, 116, 2, 422–518Publication Date (Web):January 12, 2016Publication History Received6 July 2015Published online12 January 2016Published inissue 27 January 2016https://pubs.acs.org/doi/10.1021/acs.chemrev.5b00392https://doi.org/10.1021/acs.chemrev.5b00392review-articleACS PublicationsCopyright © 2016 American Chemical SocietyRequest reuse permissionsArticle Views31495Altmetric-Citations2070LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Chemical structure,Fluorine,Inhibitors,Pharmaceuticals,Reaction products Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Self-citationInhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
The Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292
Catalysis for fluorination and trifluoromethylation
Furuya, T., Kamlet, A. S., & Ritter, T. (2011) · Nature · doi:10.1038/nature10108 · Cited by 2,215
Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960803q · Cited by 1,965
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R. A., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2130 · Cited by 1,829
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Furman, R. R., Sharman, J. P., Coutre, S. E., Cheson, B. D., Pagel, J. M., Hillmen, P., Barrientos, J. C., Zelenetz, A. D., Kipps, T. J., Flinn, I., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315226 · Cited by 1,710
Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Electrophilic Trifluoromethylation by Use of Hypervalent Iodine Reagents
Charpentier, J., Früh, N., & Togni, A. (2015) · Chemical Reviews · doi:10.1021/cr500223h · Cited by 1,573
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Organic fluorine compounds: a great opportunity for enhanced materials properties
Berger, R., Resnati, G., Metrangolo, P., Weber, E., & Hulliger, J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00221f · Cited by 1,514
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
Weisberg, E., Manley, P. W., Breitenstein, W., Brüggen, J., Cowan-Jacob, S. W., Ray, A., Huntly, B., Fabbro, D., Fendrich, G., Hall-Meyers, E., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.007 · Cited by 1,492
Liang, Y., Feng, D., Wu, Y., Tsai, S.-T., Li, G., Ray, C., & Yu, L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901545q · Cited by 1,387
Yang, X., Wu, T., Phipps, R. J., & Toste, F. D. (2015) · Chemical Reviews · doi:10.1021/cr500277b · Cited by 1,383
Wilhelm, S. M., Dumas, J., Adnane, L., Lynch, M., Carter, C. A., Schütz, G., Thierauch, K., & Zopf, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.25864 · Cited by 1,355
Yakes, F. M., Chen, J., Tan, J., Yamaguchi, K., Shi, Y., Yu, P., Qian, F., Chu, F., Bentzien, F., Cancilla, B., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0264 · Cited by 1,336
Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis
Nagib, D. A., & MacMillan, D. W. C. (2011) · Nature · doi:10.1038/nature10647 · Cited by 1,327
The Unique Role of Fluorine in the Design of Active Ingredients for Modern Crop Protection
Jeschke, P. (2004) · ChemBioChem · doi:10.1002/cbic.200300833 · Cited by 1,325
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives
McGrath, N. A., Brichacek, M., & Njardarson, J. T. (2010) · Journal of Chemical Education · doi:10.1021/ed1003806 · Cited by 1,188
Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
Kirk, K. L. (2008) · Organic Process Research & Development · doi:10.1021/op700134j · Cited by 1,151
Fluorine in medicinal chemistry: A review of anti-cancer agents
Isanbor, C., & O’Hagan, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.01.011 · Cited by 1,120
Trifluoromethyltrimethylsilane: Nucleophilic Trifluoromethylation and Beyond
Liu, X., Xu, C., Wang, M., & Liu, Q. (2015) · Chemical Reviews · doi:10.1021/cr400473a · Cited by 1,091
Ghany, M. G., Nelson, D. R., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2011) · Hepatology · doi:10.1002/hep.24641 · Cited by 1,076
Carbon Trifluoromethylation Reactions of Hydrocarbon Derivatives and Heteroarenes
Alonso, C., Martínez de Marigorta, E., Rubiales, G., & Palacios, F. (2015) · Chemical Reviews · doi:10.1021/cr500368h · Cited by 1,073
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Perfluoroalkylation with Organosilicon Reagents
Prakash, G. K. S., & Yudin, A. K. (1997) · Chemical Reviews · doi:10.1021/cr9408991 · Cited by 1,027
Enantioselective α-Trifluoromethylation of Aldehydes via Photoredox Organocatalysis
Nagib, D. A., Scott, M. E., & MacMillan, D. W. C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9053338 · Cited by 988
Monofluorination of Organic Compounds: 10 Years of Innovation
Champagne, P. A., Desroches, J., Hamel, J.-D., Vandamme, M., & Paquin, J.-F. (2015) · Chemical Reviews · doi:10.1021/cr500706a · Cited by 963
Miller, V. A., Hirsh, V., Cadranel, J., Chen, Y.-M., Park, K., Kim, S.-W., Zhou, C., Su, W.-C., Wang, M., Sun, Y., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70087-6 · Cited by 961
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Gao, M., Nettles, R. E., Belema, M., Snyder, L. B., Nguyen, V. N., Fridell, R. A., Serrano-Wu, M. H., Langley, D. R., Sun, J.-H., O’Boyle II, D. R., et al. (2010) · Nature · doi:10.1038/nature08960 · Cited by 939
New fluorinating reagents. Dialkylaminosulfur fluorides
Middleton, W. J. (1975) · The Journal of Organic Chemistry · doi:10.1021/jo00893a007 · Cited by 906
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
Kirk, K. L. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.06.007 · Cited by 900
Update 1 of: Asymmetric Fluorination, Trifluoromethylation, and Perfluoroalkylation Reactions
Ma, J.-A., & Cahard, D. (2008) · Chemical Reviews · doi:10.1021/cr800221v · Cited by 892
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Solca, F., Dahl, G., Zoephel, A., Bader, G., Sanderson, M., Klein, C., Kraemer, O., Himmelsbach, F., Haaksma, E., & Adolf, G. R. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197756 · Cited by 865
Fluorine in health care: Organofluorine containing blockbuster drugs
O’Hagan, D. (2010) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2010.03.003 · Cited by 856
Ahrens, T., Kohlmann, J., Ahrens, M., & Braun, T. (2015) · Chemical Reviews · doi:10.1021/cr500257c · Cited by 843
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Modern Carbon–Fluorine Bond Forming Reactions for Aryl Fluoride Synthesis
Campbell, M. G., & Ritter, T. (2015) · Chemical Reviews · doi:10.1021/cr500366b · Cited by 766
Innate C-H trifluoromethylation of heterocycles
Ji, Y., Brueckl, T., Baxter, R. D., Fujiwara, Y., Seiple, I. B., Su, S., Blackmond, D. G., & Baran, P. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109059108 · Cited by 757
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Wedge, S. R., Kendrew, J., Hennequin, L. F., Valentine, P. J., Barry, S. T., Brave, S. R., Smith, N. R., James, N. H., Dukes, M., Curwen, J. O., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4409 · Cited by 714
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634
Summa, V., Petrocchi, A., Bonelli, F., Crescenzi, B., Donghi, M., Ferrara, M., Fiore, F., Gardelli, C., Gonzalez Paz, O., Hazuda, D. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800245z · Cited by 633
Lennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V. R., Berger, D. S., Zhao, J., Xu, X., Williams-Diaz, A., Rodgers, A. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60918-1 · Cited by 625
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
Recent advances (1995–2005) in fluorinated pharmaceuticals based on natural products
Bégué, J.-P., & Bonnet-Delpon, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.05.006 · Cited by 600
Electrophilic Perfluoroalkylating Agents
Umemoto, T. (1996) · Chemical Reviews · doi:10.1021/cr941149u · Cited by 599
The unique role of halogen substituents in the design of modern agrochemicals
Jeschke, P. (2010) · Pest Management Science · doi:10.1002/ps.1829 · Cited by 593
Menear, K. A., Adcock, C., Boulter, R., Cockcroft, X.-L., Copsey, L., Cranston, A., Dillon, K. J., Drzewiecki, J., Garman, S., Gomez, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001263 · Cited by 584
Son, H. J., Wang, W., Xu, T., Liang, Y., Wu, Y., Li, G., & Yu, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108601g · Cited by 575
Stuart, A. C., Tumbleston, J. R., Zhou, H., Li, W., Liu, S., Ade, H., & You, W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309289u · Cited by 561
Javitt, D. C. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78003-5 · Cited by 560
Kurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4145 · Cited by 550
NO-independent regulatory site on soluble guanylate cyclase
Stasch, J.-P., Becker, E. M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Minuth, T., Perzborn, E., Pleiß, U., et al. (2001) · Nature · doi:10.1038/35065611 · Cited by 545
Maira, S.-M., Pecchi, S., Huang, A., Burger, M., Knapp, M., Sterker, D., Schnell, C., Guthy, D., Nagel, T., Wiesmann, M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0474 · Cited by 529
19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications
Tirotta, I., Dichiarante, V., Pigliacelli, C., Cavallo, G., Terraneo, G., Bombelli, F. B., Metrangolo, P., & Resnati, G. (2015) · Chemical Reviews · doi:10.1021/cr500286d · Cited by 521
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
Zhu, W., Wang, J., Wang, S., Gu, Z., Aceña, J. L., Izawa, K., Liu, H., & Soloshonok, V. A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.026 · Cited by 493
Self-citationEfficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
Yale, J. ‐., Bakris, G., Cariou, B., Yue, D., David‐Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., & Meininger, G. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12090 · Cited by 487
RECENT ADVANCES IN FLUORINATED PHARMACEUTICALS BASED ON NATURAL PRODUCTS
Hai-tao, Y. (2006) · Cited by 483
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Gauthier, J. Y., Chauret, N., Cromlish, W., Desmarais, S., Duong, L. T., Falgueyret, J.-P., Kimmel, D. B., Lamontagne, S., Léger, S., LeRiche, T., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.047 · Cited by 477
Enantioselective Formation of Stereogenic Carbon–Fluorine Centers by a Simple Catalytic Method
Marigo, M., Fielenbach, D., Braunton, A., Kjærsgaard, A., & Jørgensen, K. A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500395 · Cited by 474
Studer, A., Hadida, S., Ferritto, R., Kim, S.-Y., Jeger, P., Wipf, P., & Curran, D. P. (1997) · Science · doi:10.1126/science.275.5301.823 · Cited by 470
Chemistry with [18F]Fluoride Ion
Cai, L., Lu, S., & Pike, V. W. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800114 · Cited by 469
Electrophilic NF Fluorinating Agents
Lal, G. S., Pez, G. P., & Syvret, R. G. (1996) · Chemical Reviews · doi:10.1021/cr941145p · Cited by 461
High-resolution crystal structure of human protease-activated receptor 1
Zhang, C., Srinivasan, Y., Arlow, D. H., Fung, J. J., Palmer, D., Zheng, Y., Green, H. F., Pandey, A., Dror, R. O., Shaw, D. E., et al. (2012) · Nature · doi:10.1038/nature11701 · Cited by 455
Salwiczek, M., Nyakatura, E. K., Gerling, U. I. M., Ye, S., & Koksch, B. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15241f · Cited by 452
Mutagenicity of Nitroaromatic Compounds
Purohit, V., & Basu, A. K. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000002x · Cited by 450
Enantioselective Organocatalytic α-Fluorination of Aldehydes
Beeson, T. D., & MacMillan, D. W. C. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051805f · Cited by 424
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
Jamieson, C., Moir, E. M., Rankovic, Z., & Wishart, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060379l · Cited by 423
Rosenstock, J., Aggarwal, N., Polidori, D., Zhao, Y., Arbit, D., Usiskin, K., Capuano, G., Canovatchel, W., & for the Canagliflozin DIA 2001 Study Group (2012) · Diabetes Care · doi:10.2337/dc11-1926 · Cited by 421
Fry, D. W., Bridges, A. J., Denny, W. A., Doherty, A., Greis, K. D., Hicks, J. L., Hook, K. E., Keller, P. R., Leopold, W. R., Loo, J. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.12022 · Cited by 418
Nicholls, S. J., Brewer, H. B., Kastelein, J. J. P., Krueger, K. A., Wang, M.-D., Shao, M., Hu, B., McErlean, E., & Nissen, S. E. (2011) · JAMA · doi:10.1001/jama.2011.1649 · Cited by 410
YC-1, a novel activator of platelet guanylate cyclase
Ko, F., Wu, C., Kuo, S., Lee, F., & Teng, C. (1994) · Blood · doi:10.1182/blood.v84.12.4226.bloodjournal84124226 · Cited by 402
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?
FASS, R., SHAPIRO, M., DEKEL, R., & SEWELL, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02531.x · Cited by 394
Nomura, S., Sakamaki, S., Hongu, M., Kawanishi, E., Koga, Y., Sakamoto, T., Yamamoto, Y., Ueta, K., Kimata, H., Nakayama, K., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100332n · Cited by 385
Anhydrous Tetrabutylammonium Fluoride
Sun, H., & DiMagno, S. G. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0440497 · Cited by 381
Huang, W.-S., Metcalf, C. A., Sundaramoorthi, R., Wang, Y., Zou, D., Thomas, R. M., Zhu, X., Cai, L., Wen, D., Liu, S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100395q · Cited by 369
Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents
Liu, S., Neidhardt, E. A., Grossman, T. H., Ocain, T., & Clardy, J. (2000) · Structure · doi:10.1016/s0969-2126(00)00077-0 · Cited by 345
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600139 · Cited by 328
9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONE
Fried, J., & Sabo, E. F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01634a101 · Cited by 323
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Hatzivassiliou, G., Haling, J. R., Chen, H., Song, K., Price, S., Heald, R., Hewitt, J. F. M., Zak, M., Peck, A., Orr, C., et al. (2013) · Nature · doi:10.1038/nature12441 · Cited by 319
Fluorinated amino acids in protein design and engineering
Yoder, N. C., & Kumar, K. (2002) · Chemical Society Reviews · doi:10.1039/b201097f · Cited by 317
Tachykinins and Tachykinin Receptors: Structure and Activity Relationships
Almeida, T. A., Rojo, J., Nieto, P. M., Pinto, F. M., Hernandez, M., Martín, J. D., & Candenas, M. L. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364748 · Cited by 310
Gergely, P., Nuesslein‐Hildesheim, B., Guerini, D., Brinkmann, V, Traebert, M., Bruns, C., Pan, S., Gray, N., Hinterding, K., Cooke, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02061.x · Cited by 305
Matulonis, U. A., Berlin, S., Ivy, P., Tyburski, K., Krasner, C., Zarwan, C., Berkenblit, A., Campos, S., Horowitz, N., Cannistra, S. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2777 · Cited by 302
Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60230-0 · Cited by 299
Link, J. O., Taylor, J. G., Xu, L., Mitchell, M., Guo, H., Liu, H., Kato, D., Kirschberg, T., Sun, J., Squires, N., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401499g · Cited by 295
Self-citationThe discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
Barrett, S. D., Bridges, A. J., Dudley, D. T., Saltiel, A. R., Fergus, J. H., Flamme, C. M., Delaney, A. M., Kaufman, M., LePage, S., Leopold, W. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.054 · Cited by 289
Blonanserin: A Review of its Use in the Management of Schizophrenia
Deeks, E. D., & Keating, G. M. (2010) · CNS Drugs · doi:10.2165/11202620-000000000-00000 · Cited by 289
Structure-activity relationships of the fluoroquinolones
Chu, D. T., & Fernandes, P. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.131 · Cited by 284
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
Clar, C., Gill, J. A., Court, R., & Waugh, N. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001007 · Cited by 282
Krishna, R., Anderson, M. S., Bergman, A. J., Jin, B., Fallon, M., Cote, J., Rosko, K., Chavez-Eng, C., Lutz, R., Bloomfield, D. M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61813-3 · Cited by 277
Tsou, H.-R., Mamuya, N., Johnson, B. D., Reich, M. F., Gruber, B. C., Ye, F., Nilakantan, R., Shen, R., Discafani, C., DeBlanc, R., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0005555 · Cited by 271
Smaill, J. B., Rewcastle, G. W., Loo, J. A., Greis, K. D., Chan, O. H., Reyner, E. L., Lipka, E., Showalter, H. D. H., Vincent, P. W., Elliott, W. L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990482t · Cited by 269
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
Besset, T., Poisson, T., & Pannecoucke, X. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201404537 · Cited by 269
Jung, M. E., Ouk, S., Yoo, D., Sawyers, C. L., Chen, C., Tran, C., & Wongvipat, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901488g · Cited by 266
Ramalingam, S. S., Blackhall, F., Krzakowski, M., Barrios, C. H., Park, K., Bover, I., Seog Heo, D., Rosell, R., Talbot, D. C., Frank, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9433 · Cited by 264
The Structure of Dimeric ROCK I Reveals the Mechanism for Ligand Selectivity
Jacobs, M., Hayakawa, K., Swenson, L., Bellon, S., Fleming, M., Taslimi, P., & Doran, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508847200 · Cited by 261
Polidori, D., Sha, S., Mudaliar, S., Ciaraldi, T. P., Ghosh, A., Vaccaro, N., Farrell, K., Rothenberg, P., & Henry, R. R. (2013) · Diabetes Care · doi:10.2337/dc12-2391 · Cited by 261
HIV Integrase, a Brief Overview from Chemistry to Therapeutics
Craigie, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100027200 · Cited by 258
Forst, T., Guthrie, R., Goldenberg, R., Yee, J., Vijapurkar, U., Meininger, G., & Stein, P. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12273 · Cited by 255
Oku, A., Ueta, K., Arakawa, K., Ishihara, T., Nawano, M., Kuronuma, Y., Matsumoto, M., Saito, A., Tsujihara, K., Anai, M., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1794 · Cited by 254
Rheault, T. R., Stellwagen, J. C., Adjabeng, G. M., Hornberger, K. R., Petrov, K. G., Waterson, A. G., Dickerson, S. H., Mook, R. A., Laquerre, S. G., King, A. J., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000063 · Cited by 253
Burger, M. T., Pecchi, S., Wagman, A., Ni, Z.-J., Knapp, M., Hendrickson, T., Atallah, G., Pfister, K., Zhang, Y., Bartulis, S., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200156t · Cited by 252
Hoeflich, K. P., Merchant, M., Orr, C., Chan, J., Den Otter, D., Berry, L., Kasman, I., Koeppen, H., Rice, K., Yang, N.-Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1515 · Cited by 242
Ripasudil: First Global Approval
Garnock-Jones, K. P. (2014) · Drugs · doi:10.1007/s40265-014-0333-2 · Cited by 242
Expert opinion on the treatment of patients with chronic hepatitis C
Zeuzem, S., Berg, T., Moeller, B., Hinrichsen, H., Mauss, S., Wedemeyer, H., Sarrazin, C., Hueppe, D., Zehnter, E., & Manns, M. P. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01012.x · Cited by 242
Huchet, Q. A., Kuhn, B., Wagner, B., Kratochwil, N. A., Fischer, H., Kansy, M., Zimmerli, D., Carreira, E. M., & Müller, K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01455 · Cited by 239
Sasaki, Y., Suzuki, M., & Hidaka, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00191-2 · Cited by 234
Selmaj, K., Li, D. K., Hartung, H.-P., Hemmer, B., Kappos, L., Freedman, M. S., Stüve, O., Rieckmann, P., Montalban, X., Ziemssen, T., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70102-9 · Cited by 234
Soloshonok, V. A. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503373 · Cited by 227
Self-citationKishi, T., Matsuda, Y., Nakamura, H., & Iwata, N. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.011 · Cited by 221
Yang, J., Bahk, W.-M., Cho, H.-S., Jeon, Y.-W., Jon, D.-I., Jung, H.-Y., Kim, C.-H., Kim, H.-C., Kim, Y.-K., Kim, Y.-H., et al. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181dcda50 · Cited by 220
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
Blanco, J.-L., Varghese, V., Rhee, S.-Y., Gatell, J. M., & Shafer, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir025 · Cited by 218
Guinea, J., Peláez, T., Recio, S., Torres-Narbona, M., & Bouza, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-07 · Cited by 215
Late-Stage Fluorination: From Fundamentals to Application
Campbell, M. G., & Ritter, T. (2014) · Organic Process Research & Development · doi:10.1021/op400349g · Cited by 212
Cresswell, A. J., Davies, S. G., Roberts, P. M., & Thomson, J. E. (2015) · Chemical Reviews · doi:10.1021/cr5001805 · Cited by 210
The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation
Quartara, L., & Maggi, C. A. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90001-9 · Cited by 205
Using 19F NMR to Probe Biological Interactions of Proteins and Peptides
Marsh, E. N. G., & Suzuki, Y. (2014) · ACS Chemical Biology · doi:10.1021/cb500111u · Cited by 203
O'Hare, T., Pollock, R., Stoffregen, E. P., Keats, J. A., Abdullah, O. M., Moseson, E. M., Rivera, V. M., Tang, H., Metcalf, C. A., Bohacek, R. S., et al. (2004) · Blood · doi:10.1182/blood-2004-05-1851 · Cited by 200
Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
Juillerat-Jeanneret, L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400658e · Cited by 198
Recent Advances in the Synthesis of Fluorinated Amino Acids
Qiu, X., & Qing, F. (2011) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201100032 · Cited by 196
l-Nucleoside enantiomers as antivirals drugs: A mini-review
Mathé, C., & Gosselin, G. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.04.017 · Cited by 196
Brickner, S. J., Barbachyn, M. R., Hutchinson, D. K., & Manninen, P. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800038g · Cited by 196
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)
Abe, H., Kikuchi, S., Hayakawa, K., Iida, T., Nagahashi, N., Maeda, K., Sakamoto, J., Matsumoto, N., Miura, T., Matsumura, K., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200004g · Cited by 196
Gao, W., Reiser, P. J., Coss, C. C., Phelps, M. A., Kearbey, J. D., Miller, D. D., & Dalton, J. T. (2005) · Endocrinology · doi:10.1210/en.2005-0572 · Cited by 192
Williamson, R. A., Yea, C. M., Robson, P. A., Curnock, A. P., Gadher, S., Hambleton, A. B., Woodward, K., Bruneau, J.-M., Hambleton, P., Moss, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22467 · Cited by 192
Fluorinated Proteins: From Design and Synthesis to Structure and Stability
Marsh, E. N. G. (2014) · Accounts of Chemical Research · doi:10.1021/ar500125m · Cited by 190
Tanihara, H., Inoue, T., Yamamoto, T., Kuwayama, Y., Abe, H., & Araie, M. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.05.016 · Cited by 190
Olaparib: First Global Approval
Deeks, E. D. (2015) · Drugs · doi:10.1007/s40265-015-0345-6 · Cited by 188
Johns, B. A., Kawasuji, T., Weatherhead, J. G., Taishi, T., Temelkoff, D. P., Yoshida, H., Akiyama, T., Taoda, Y., Murai, H., Kiyama, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400645w · Cited by 186
Mittendorf, J., Weigand, S., Alonso‐Alija, C., Bischoff, E., Feurer, A., Gerisch, M., Kern, A., Knorr, A., Lang, D., Muenter, K., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900014 · Cited by 186
Development of specific Rho-kinase inhibitors and their clinical application
Tamura, M., Nakao, H., Yoshizaki, H., Shiratsuchi, M., Shigyo, H., Yamada, H., Ozawa, T., Totsuka, J., & Hidaka, H. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.06.015 · Cited by 178
Smaill, J. B., Palmer, B. D., Rewcastle, G. W., Denny, W. A., McNamara, D. J., Dobrusin, E. M., Bridges, A. J., Zhou, H., Showalter, H. D. H., Winters, R. T., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806603 · Cited by 177
Morrow, D. A., Scirica, B. M., Fox, K. A. A., Berman, G., Strony, J., Veltri, E., Bonaca, M. P., Fish, P., McCabe, C. H., & Braunwald, E. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.027 · Cited by 172
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
Pan, S., Gray, N. S., Gao, W., Mi, Y., Fan, Y., Wang, X., Tuntland, T., Che, J., Lefebvre, S., Chen, Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300396r · Cited by 171
Fluorous Linker-Facilitated Chemical Synthesis
Zhang, W. (2009) · Chemical Reviews · doi:10.1021/cr800412s · Cited by 170
Schmitt-Hoffmann, A., Roos, B., Heep, M., Schleimer, M., Weidekamm, E., Brown, T., Roehrle, M., & Beglinger, C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.279-285.2006 · Cited by 170
Recent Advances in the Asymmetric Synthesis of α-(Trifluoromethyl)-Containing α-Amino Acids
Aceña, J., Soloshonok, V., & Sorochinsky, A. (2012) · Synthesis · doi:10.1055/s-0031-1289756 · Cited by 168
Self-citationFluorine in Peptide Design and Protein Engineering
Jäckel, C., & Koksch, B. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200500205 · Cited by 167
Rice, K. D., Aay, N., Anand, N. K., Blazey, C. M., Bowles, O. J., Bussenius, J., Costanzo, S., Curtis, J. K., Defina, S. C., Dubenko, L., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300049d · Cited by 167
Biftu, T., Sinha-Roy, R., Chen, P., Qian, X., Feng, D., Kuethe, J. T., Scapin, G., Gao, Y. D., Yan, Y., Krueger, D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401992e · Cited by 166
Soloshonok, V. A., Roussel, C., Kitagawa, O., & Sorochinsky, A. E. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35006h · Cited by 163
Self-citationRaltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
Serrao, E., Odde, S., Ramkumar, K., & Neamati, N. (2009) · Retrovirology · doi:10.1186/1742-4690-6-25 · Cited by 163
Protein Kinase A in Complex with Rho-Kinase Inhibitors Y-27632, Fasudil, and H-1152P
Breitenlechner, C. B., Gaßel, M., Hidaka, H., Kinzel, V., Huber, R., Engh, R. A., & Bossemeyer, D. (2003) · Structure · doi:10.1016/j.str.2003.11.002 · Cited by 162
The Discovery of Linezolid, the First Oxazolidinone Antibacterial Agent
Ford, C., Zurenko, G. E., & Barbachyn, M. R. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005014606099 · Cited by 161
Selective androgen receptor modulators in preclinical and clinical development
Narayanan, R., Mohler, M. L., Bohl, C. E., Miller, D. D., & Dalton, J. T. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06010 · Cited by 158
Dando, T. M., & Perry, C. M. (2004) · Drugs · doi:10.2165/00003495-200464070-00013 · Cited by 158
Ipragliflozin: First Global Approval
Poole, R. M., & Dungo, R. T. (2014) · Drugs · doi:10.1007/s40265-014-0204-x · Cited by 158
Jönsson, S., Andersson, G. K. A., Fex, T., Fristedt, T., Hedlund, G., Jansson, K., Abramo, L., Fritzson, I., Pekarski, O., Runström, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031044w · Cited by 157
Somoza, J. R., Koditek, D., Villaseñor, A. G., Novikov, N. Y., Wong, M. H. L., Liclican, A. C., Xing, W., Lagpacan, L., Wang, R., Schultz, B. E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634683 · Cited by 157
Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
Ramanathan, S., Mathias, A. A., German, P., & Kearney, B. P. (2011) · Clinical Pharmacokinetics · doi:10.2165/11584570-000000000-00000 · Cited by 156
Pharmacodynamics of Selective Androgen Receptor Modulators
Yin, D., Gao, W., Kearbey, J. D., Xu, H., Chung, K., He, Y., Marhefka, C. A., Veverka, K. A., Miller, D. D., & Dalton, J. T. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040840 · Cited by 156
Manley, P. W., Stiefl, N., Cowan‐Jacob, S. W., Kaufman, S., Mestan, J., Wartmann, M., Wiesmann, M., Woodman, R., & Gallagher, N. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.026 · Cited by 153
Arikawa, Y., Nishida, H., Kurasawa, O., Hasuoka, A., Hirase, K., Inatomi, N., Hori, Y., Matsukawa, J., Imanishi, A., Kondo, M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300318t · Cited by 153
Yamamoto, K. T., Maruyama, K., Himori, N., Omodaka, K., Yokoyama, Y., Shiga, Y., Morin, R., & Nakazawa, T. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13842 · Cited by 151
In vitro and pharmacophore insights into CYP3A enzymes
Ekins, S., Stresser, D. M., & Williams, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00049-x · Cited by 151
Design and Discovery of Small Molecules Targeting Raf-1 Kinase
Lowinger, T. B., Riedl, B., Dumas, J., & Smith, R. A. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393125 · Cited by 150
Sorochinsky, A. E., Aceña, J. L., Moriwaki, H., Sato, T., & Soloshonok, V. A. (2013) · Amino Acids · doi:10.1007/s00726-013-1539-4 · Cited by 148
Self-citationCai, Z., Zhang, Y., Borzilleri, R. M., Qian, L., Barbosa, S. A. L., Wei, D. D., Zheng, X., Wu, L., Fan, J., Shi, Z., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7013309 · Cited by 144
Efficient Fluoride-Catalyzed Conversion of CO2 to CO at Room Temperature
Lescot, C., Nielsen, D. U., Makarov, I. S., Lindhardt, A. T., Daasbjerg, K., & Skrydstrup, T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502911e · Cited by 144
Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini‐Silberstein, F., Malet, I., D’Arrigo, R., Antinori, A., Marcelin, A., & Perno, C. F. (2009) · PubMed · Cited by 142
Ma, T., Pai, S. B., Zhu, Y. L., Lin, J. S., Shanmuganathan, K., Du, J., Wang, C., Kim, H., Newton, M. G., Cheng, Y. C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960098l · Cited by 140
The second PGD2 receptor CRTH2: structure, properties, and functions in leukocytes
Nagata, K., & Hirai, H. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00078-4 · Cited by 140
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139
Imamura, M., Nakanishi, K., Suzuki, T., Ikegai, K., Shiraki, R., Ogiyama, T., Murakami, T., Kurosaki, E., Noda, A., Kobayashi, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.051 · Cited by 139
Practical Methods for the Synthesis of Symmetrically α,α-Disubstituted α-Amino Acids
Soloshonok, V. A., & Sorochinsky, A. E. (2010) · Synthesis · doi:10.1055/s-0029-1220013 · Cited by 138
Self-citationSorochinsky, A. E., Aceña, J. L., Moriwaki, H., Sato, T., & Soloshonok, V. A. (2013) · Amino Acids · doi:10.1007/s00726-013-1580-3 · Cited by 137
Self-citationIsavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
Thompson, G. R., & Wiederhold, N. P. (2010) · Mycopathologia · doi:10.1007/s11046-010-9324-3 · Cited by 136
Pinard, E., Alanine, A. I., Alberati, D., Bender, M., Borroni, E., Bourdeaux, P., Brom, V., Burner, S., Fischer, H., Hainzl, D., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100210p · Cited by 134
Bhide, R. S., Cai, Z., Zhang, Y., Qian, L., Wei, D. D., Barbosa, S. A. L., Lombardo, L. J., Borzilleri, R. M., Zheng, X., Wu, L. I., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051106d · Cited by 133
Stasch, J., Alonso‐Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Minuth, T., Perzborn, E., Schramm, M., & Straub, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704484 · Cited by 132
Stereoselective C-Glycosylation Reactions with Arylzinc Reagents
Lemaire, S., Houpis, I. N., Xiao, T., Li, J., Digard, E., Gozlan, C., Liu, R., Gavryushin, A. E., Diène, C. R., Wang, Y., et al. (2012) · Organic Letters · doi:10.1021/ol300220p · Cited by 132
Kulke, M. H., O’Dorisio, T. M., Phan, A. T., Bergsland, E. K., Law, L., Banks, P. L., Freiman, J. P., Frazier, K., Jackson, J. R., Yao, J. C., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0173 · Cited by 130
Mechanosynthesis of amides in the total absence of organic solvent from reaction to product recovery
Métro, T., Bonnamour, J., Reidon, T., Sarpoulet, J., Martínez, J., & Lamaty, F. (2012) · Chemical Communications · doi:10.1039/c2cc36352f · Cited by 130
Blackie, J. A., Bloomer, J. C., Brown, M. J. B., Cheng, H., Hammond, B., Hickey, D. M. B., Ife, R. J., Leach, C. A., Lewis, V. A., Macphee, C. H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00058-1 · Cited by 128
Ketolides—telithromycin, an example of a new class of antibacterial agents
Bryskier, A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00185.x · Cited by 127
Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV
Zhang, Z., Wallace, M. B., Feng, J., Stafford, J. A., Skene, R. J., Shi, L., Lee, B., Aertgeerts, K., Jennings, A. J., Xu, R., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101016w · Cited by 127
Aceña, J. L., Sorochinsky, A. E., & Soloshonok, V. A. (2014) · Amino Acids · doi:10.1007/s00726-014-1764-5 · Cited by 124
Self-citationChen, C., Wu, D., Guo, Z., Xie, Q., Reinhart, G. J., Madan, A., Wen, J., Chen, T., Huang, C. Q., Mi, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006454 · Cited by 120
Idelalisib: First Global Approval
Markham, A. (2014) · Drugs · doi:10.1007/s40265-014-0285-6 · Cited by 119
Polidori, D., Mari, A., & Ferrannini, E. (2014) · Diabetologia · doi:10.1007/s00125-014-3196-x · Cited by 117
Cao, G., Beyer, T. P., Zhang, Y., Schmidt, R. J., Chen, Y., Cockerham, S. L., Zimmerman, K. M., Karathanasis, S. K., Cannady, E. A., Fields, T., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018069 · Cited by 116
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
Pasqualotto, A. C., & Falci, D. R. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s51340 · Cited by 115
Scherer, K. V., Ono, T., Yamanouchi, K., Fernandez, R. E., Henderson, P. B., & Goldwhite, H. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00289a042 · Cited by 113
Cited by
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Electrochemical strategies for C–H functionalization and C–N bond formation
Kärkäs, M. D. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00619e · Cited by 1,003
Kaiser, D., Klose, I., Oost, R., Neuhaus, J., & Maulide, N. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00111 · Cited by 887
Buglioni, L., Raymenants, F., Slattery, A., Zondag, S. D. A., & Noël, T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00332 · Cited by 781
The unique fluorine effects in organic reactions: recent facts and insights into fluoroalkylations
Ni, C., & Hu, J. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00351f · Cited by 737
Metadata
- Authors
- Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-01-12
- Volume
- 116
- Issue
- 2
- Pages
- 422-518
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2237872262
- Cited by
- 2,808
- References
- 359
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.